Arkolith/Insider Trading/ATOS/Form 4

Remmel H. Lawrence

DirectorATOSSA THERAPEUTICS, INC. (ATOS) · full profile →Form 4 · filed Mar 28, 2025
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2025Buy(P)10K$0.70$7K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-046742) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML